N-glycosylated antigens have been widely used as biomarkers for different types of cancers: alpha-fetoprotein (AFP) for HCC, PSA for prostate cancer, and carbohydrate antigen 19-9 (CA19-9) for CCA. This evidence concerns the gene AFP and Familial prostate cancer.